Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    A GlaxoSmithKline scientist uses a microscope
    Investing Articles

    Should I act on the GlaxoSmithKline share price or buy AstraZeneca instead?

    | Christopher Ruane

    Our writer considers whether the GlaxoSmithKline share price could make it an attractive addition for his portfolio, compared to rival…

    Read more »

    Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
    Investing Articles

    Why AstraZeneca stock is a buy right now

    | Ed Jones

    Fool contributor Ed Jones provides three reasons why he's bullish on AstraZeneca stock and is considering adding it to his…

    Read more »

    Investing Articles

    2022 dividend forecasts: HSBC, AstraZeneca, Glencore

    | Roland Head

    These FTSE 100 stocks are popular income picks, but how much will they payout in 2022? Roland Head looks at…

    Read more »

    Investing Articles

    1 FTSE 100 stock I wouldn’t miss buying in November

    | Manika Premsingh

    This FTSE 100 stock has seen a decline in share price in recent months. But that might be about to…

    Read more »

    Investing Articles

    2 FTSE 100 dividend stocks I’d aim to never sell

    | Kevin Godbold

    I wouldn't try to hold all my investments forever, but these two FTSE 100 dividend stocks both have many qualities…

    Read more »

    Syringe and vial on blue background
    Investing Articles

    AstraZeneca (LON:AZN) makes progress in the fight against liver cancer

    | Zaven Boyrazian, MSc

    The AstraZeneca (LON:AZN) share price idles despite the firm reporting positive results from its liver cancer clinical trials.

    Read more »

    Investing Articles

    These 2 FTSE 100 stocks are beaten down bargains in my opinion!

    | Jabran Khan

    This Fool identifies two FTSE 100 picks he believes are beaten down stocks that could be potential bargains with upside…

    Read more »

    Investing Articles

    Why I’d buy AstraZeneca shares today

    | Alexander Fazel

    AstraZeneca shares have rallied since the vaccine rollout. As we move into a post-pandemic world, I discuss why AstraZeneca piques…

    Read more »

    Investing Articles

    3 FTSE 100 stocks to buy for the long term

    | Manika Premsingh

    These FTSE 100 stocks are among the biggest gainers today, but this Fool reckons that their long-term prospects are good…

    Read more »

    Investing Articles

    2 UK shares to buy now for growth

    | Christopher Ruane

    From his list of top UK shares to buy now for his portfolio, our writer considers two firms whose growth…

    Read more »

    Investing Articles

    AstraZeneca (AZN) shares gain on acquisition news

    | Alan Oscroft

    AstraZeneca (LON: AZN) expands its presence in rare disease development with a further acquisition, sending its shares higher.

    Read more »

    Syringe and vial on blue background
    Investing Articles

    The Oxford Biomedica share price has doubled since signing its Covid-19 vaccine deal. Can the momentum continue?

    | Megan Boxall

    Oxford Biomedica’s share price is soaring. But is this simply the hype of its Covid-19 vaccine deal? Megan Boxall examines…

    Read more »